• 4751 Citations
  • 38 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Sang Yoon Park is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 25 Similar Profiles
Uterine Cervical Neoplasms Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Endometrial Neoplasms Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Lymph Nodes Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Korea Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2019

1 Citation (Scopus)

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

TRINOVA-3/ENGOT-ov2/GOG-3001 investigators, 1 Jun 2019, In : The Lancet Oncology. 20, 6, p. 862-876 15 p.

Research output: Contribution to journalArticleResearchpeer-review

Ovarian Neoplasms
Disease-Free Survival

Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: A Korean multicenter study

Kim, M., Kwon, B. S., Chang, H. K., Lee, S., Chang, S. J., Choi, J. Y., Park, S. Y., Lee, M., Ryu, H. S. & Kim, Y. B., 1 May 2019, In : Journal of Gynecologic Oncology. 30, 3, e44.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Adjuvant Radiotherapy
Papillary Carcinoma
Adjuvant Chemotherapy
Endometrial Neoplasms
Multicenter Studies

Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: A Korean gynecologic oncology group study (OV 1708)

Chung, Y. S., Park, S. Y., Lee, J. Y., Park, J. Y., Lee, J. W., Kim, H. S., Suh, D. S., Kim, Y. H., Lee, J. M., Kim, M., Choi, M. C., Shim, S. H., Lee, K. H., Song, T., Hong, J. H., Lee, W. M., Lee, B. & Lee, I. H., 11 Apr 2019, In : BMC Cancer. 19, 1, 341.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
Ovarian Neoplasms
Drug Therapy
Disease-Free Survival

Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy

Cheong, I. Y., Yoo, J. S., Chung, S. H., Park, S. Y., Song, H. J., Lee, J. W. & Hwang, J. H., 2 Apr 2019, In : Archives of Gynecology and Obstetrics. 299, 4, p. 1063-1069 7 p.

Research output: Contribution to journalArticleResearchpeer-review

Ovarian Neoplasms
Drug Therapy
Activities of Daily Living
Second Primary Neoplasms

Delayed IL-21 treatment preferentially expands peptide-specific CD8+ T cells by reducing bystander activation of T cells

Kim, S. H., Park, S. Y., Lim, M. C., Lee, E. S., Lee, E. G., Han, S. E., Kim, Y. H., Kwon, B. S. & Choi, B. K., 1 Apr 2019, In : Immunotherapy. 11, 6, p. 497-513 17 p.

Research output: Contribution to journalArticleResearchpeer-review

Wilms Tumor